DJIA 18,118.68 -44.31 -0.24%
NASDAQ 5,097.03 -9.57 -0.19%
S&P 500 2,120.41 -3.07 -0.14%
market minute promo

Vertex Pharmaceuticals (NASDAQ: VRTX)

company name or ticker
Company Photos
(Click to zoom)

Lee Ainslie Adds 90 New Stocks to His Portfolio Within the First Quarter

3 Types of Risks Facing Biotech Stocks

Biotech stocks have been dramatically outperforming the broader market, but that doesn't mean they're free of risk. Here are three types of risks all biotech stocks face.

Could This Tiny Biotech Be on Gilead Sciences’ M&A Radar?

Gilead Sciences is on the the prowl for potential buyout targets. This little-known immuno-therapy company looks like a perfect match for the biotech in many ways. Here's why.

S&P 500 Movers: GMCR, NFLX

Vertex: The FDA Advisory Committee Recommended Approval For Orkambi

Nasdaq 100 Movers: VRTX, VIP

Vertex Pharmaceuticals' Orkambi Wins FDA Panel Backing - Analyst Blog

Analysts Confident That Vertex Pharmaceuticals' CF Drug Will Receive FDA Approval

Biotech Stock Roundup: Alexion to Buy Synageva, FDA Panel Backs Vertex's Orkambi - Analyst Blog

Vertex Pharmaceuticals (VRTX) Stock Climbs Following FDA Advisory Panel Aprroval

See More Articles...